Vistagen Therapeutics (VTGN) Notes Payables (2011 - 2025)
Vistagen Therapeutics (VTGN) posted Notes Payables of $400000.0 for Q4 2025, down 39.21% sequentially from $658000.0 in Q3 2025.
Vistagen Therapeutics (VTGN) Notes Payables (2011 - 2025) Analysis & Trends
Vistagen Therapeutics has reported Notes Payables for 12 years, with the latest figure at $400000.0 in Q4 2025.
- Quarterly Notes Payables changed N/A year-over-year to $400000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $400000.0 (changed N/A YoY) and the FY2023 annual result came in at $105000.0, changed N/A from the prior year.
- Notes Payables fell to $400000.0 in Q4 2025 per VTGN's latest filing, from $658000.0 in the prior quarter.
- Over five years, Notes Payables peaked at $1.0 million in Q2 2022 and troughed at $105000.0 in Q1 2023.
- A 3-year average of $633387.5 and a median of $694000.0 in 2022 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 24.44% in 2023, down 24.44% in 2023.
- Over 3 years, Notes Payables stood at $419100.0 in 2022, then soared by 87.12% to $784200.0 in 2023, then tumbled by 48.99% to $400000.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $400000.0, $658000.0, and $933000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - |
| 10 | Vistagen Therapeutics | 10.42 Mn | 10.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 658,000.00 |
| Jun 30, 2025 | 933,000.00 |
| Jun 30, 2023 | 784,200.00 |
| Mar 31, 2023 | 105,000.00 |
| Dec 31, 2022 | 419,100.00 |
| Sep 30, 2022 | 730,000.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2020 | 56,500.00 |
| Mar 31, 2019 | 57,300.00 |
| Mar 31, 2018 | 53,900.00 |
| Mar 31, 2017 | 54,800.00 |
| Mar 31, 2016 | 43,600.00 |
| Jun 30, 2014 | 1.96 Mn |
| Mar 31, 2014 | 396,000.00 |
| Dec 31, 2013 | 2.48 Mn |
| Sep 30, 2013 | 2.35 Mn |
| Jun 30, 2013 | 6.95 Mn |
| Mar 31, 2013 | 1.80 Mn |
| Dec 31, 2012 | 1.91 Mn |